Compared with their counterparts with −1195GG and −1195GA, the patients with −1195dupA showed significantly increased COX-2 expression in vitro and in vivo, showing that functional −1195G>A SNP, which might influence the expression of COX-2, led to decreased survival in NSCLC independently. The gene discussed is PTGS2; the disease is non-small cell lung carcinoma.